Here is the link to the PDF of the WHO’s latest draft pandemic treaty: https://lovinglifetv.com/wp-content/uploads/Proposal_For_The_Who_Pandemic_Agreement.pdf
Here is an extract from Article 11 – page 11:
Each Party shall, in order to enable sufficient, sustainable and geographically-diversified production of pandemic-related health products, and taking into account its national circumstances:
(a) promote and otherwise facilitate or incentivize the transfer of technology and know-how for pandemic-related health products, in particular for the benefit of developing countries and for technologies that have received public funding for their development, through a variety of measures such as licensing, on mutually agreed terms;
(b) publish the terms of its licenses for pandemic-related health technologies in a timely manner and in accordance with applicable law, and shall encourage private rights holders to do the same;
(c) encourage research and development institutes and manufacturers, in particular those receiving significant public financing, to forgo or reduce, for a limited duration, royalties on the use of their technology for the production of pandemic-related health products;
(d) promote the transfer of relevant technology and related know-how for pandemic-related health products, by private rights holders, on fair and most favourable terms, including on concessional and preferential terms and in accordance with mutually agreed terms and conditions, to established regional or global technology transfer hubs or other multilateral mechanisms or networks, as well as the publication of the terms of such agreements;
(e) encourage holders of relevant patents that received public funding, and where appropriate, other holders of relevant patents for pandemic-related health products, to forgo royalties or otherwise license any relevant patents at reasonable royalties to developing country manufacturers for the use, during the pandemic, of their technology and know-how for the production of pandemic-related health products; and
(f) encourage manufacturers within its jurisdiction to share as appropriate, during pandemics, information that is relevant to the production of pandemic-related health products when the withholding of such information prevents or hinders urgent manufacture of a pharmaceutical product that is necessary to respond to the pandemic.
Encourage is not a term of enforcement it will be ignored by big pharma – why not replace “encourage” with ENFORCE – this BS reflects the influence of the Bill and Melinda Gates Foundation over the World Health Organisation.
Thank you James for your commitment to LL. We appreciate people who keep their undertaking seriously. Very interesting and looking forward to the next